Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ELTXthis companyElicio Therapeutics, Inc.	$1.63	-3.09×	74.5×	0×	-3.16×	-85.8%	0.0%	0.0%	0.0%	-2418.8%	-201.0%	-30.3%	8.87×	0.11×	-33.29×	2.38×	0.0%	2	-14.29	1	D+
ACTUActuate Therapeutics Inc	$0.34	-5.77×	16.24×	0×	-5.22×	57.8%	0.0%	0.0%	0.0%	-280.5%	-270.1%	-14.9%	0.05×	0.57×	-1,110.88×	2.39×	0.0%	2	-56.06	2	C
CRBPCorbus Pharmaceuticals Holdings, Inc.	$3.51	-1.38×	0.73×	0×	-1.04×	-49.7%	0.0%	0.0%	0.0%	-53.2%	-57.2%	-59.5%	0.01×	0.34×	0×	8.07×	0.0%	1	-6.62	2	B-
CRDFCardiff Oncology, Inc.	$0.84	-4.07×	4.14×	316.73×	-3.81×	-96.7%	100.0%	-8256.3%	-7732.0%	-101.0%	-105.9%	-20.2%	0.02×	0.37×	0×	3.67×	0.0%	2	-16.02	2	C
NKTXNkarta, Inc.	$1.44	-1.31×	0.44×	0×	-1.83×	-132.8%	0.0%	0.0%	0.0%	-33.3%	-31.2%	-65.7%	0.24×	-0.39×	0×	12.69×	0.0%	1	-2.81	2	C
PEPGPepGen Inc.	$2.47	-3.07×	1.86×	0×	-2.62×	-56.9%	0.0%	0.0%	0.0%	-60.8%	-56.9%	-29.8%	0.12×	0.49×	0×	11.94×	0.0%	2	-0.25	2	C+
Peer median	—	-3.07×	1.86×	0×	-2.62×	-56.9%	0.0%	0.0%	0.0%	-60.8%	-57.2%	-29.8%	0.05×	0.37×	0×	8.07×	0.0%	2	-6.62	2	—